Glenmark Pharmaceuticals informs about withdrawal of issuer rating

23 Sep 2023 Evaluate

Glenmark Pharmaceuticals has informed that, India Ratings has discontinued and withdrawn the outstanding voluntary issuer rating disclosure of the company due to regulatory requirement. All outstanding instrument ratings remain unaffected and this action should not be construed as a change to the credit profile of the Company. The detailed report is attached.

The above information is a part of company’s filings submitted to BSE.


Glenmark Pharma Share Price

2064.50 39.10 (1.93%)
02-Jan-2026 14:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1727.20
Dr. Reddys Lab 1252.85
Cipla 1509.85
Zydus Lifesciences 916.30
Lupin 2107.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×